Viewing StudyNCT01235975



Ignite Creation Date: 2024-05-05 @ 11:01 PM
Last Modification Date: 2024-10-26 @ 10:27 AM
Study NCT ID: NCT01235975
Status: COMPLETED
Last Update Posted: 2018-08-20
First Post: 2010-11-04

Brief Title: Immunogenicity and Safety Study of GSK Biologicals Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-11-30
Start Date Type: ACTUAL
Primary Completion Date: 2011-07-29
Primary Completion Date Type: ACTUAL
Completion Date: 2011-08-03
Completion Date Type: ACTUAL
First Submit Date: 2010-11-04
First Submit QC Date: November 4 2010
Study First Post Date: 2010-11-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-04-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2012-07-23
Disp First Submit QC Date: July 23 2012
Disp First Post Date: 2012-07-31
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2018-07-19
Last Update Post Date: 2018-08-20
Last Update Post Date Type: ACTUAL